Effect of abdominal liposuction on sonographically guided high-intensity focused ultrasound ablation

J Ultrasound Med. 2014 Sep;33(9):1539-44. doi: 10.7863/ultra.33.9.1539.

Abstract

Objectives: The aim of this study was to evaluate the effect of abdominal liposuction on sonographically guided high-intensity focused ultrasound (HIFU) ablation.

Methods: A total of 10 women with uterine fibroids or adenomyosis who had received abdominal liposuction were analyzed after sonographically guided HIFU ablation. Of the 10 women, 6 had a diagnosis of uterine fibroids, and 4 had a diagnosis of uterine adenomyosis. All of them had a history of a horizontal-margin split-cesarean delivery. In addition, 26 women with a history of a single horizontal-margin split-cesarean delivery who had a diagnosis of uterine fibroids or adenomyosis but had not received liposuction were analyzed together as a control group.

Results: Of the 10 women, 1 woman with uterine fibroids developed local skin erythema after treatment; 1 women with uterine adenomyosis developed a skin burn after treatment; and the remaining women had obvious skin-burning pain during treatment. All women who had not received liposuction finished the treatment with no serious adverse events during or after treatment. The pain scores and incidence of skin-burning pain were significantly higher in the liposuction group than the control group (P= .021 and .038, respectively).

Conclusions: Abdominal liposuction may increase the risk of skin burns during sonographically guided HIFU ablation.

Keywords: adenomyosis; gynecologic ultrasound; high-intensity focused ultrasound; liposuction; uterine fibroids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abdomen / surgery*
  • Adenomyosis
  • Adult
  • Female
  • High-Intensity Focused Ultrasound Ablation*
  • Humans
  • Leiomyoma / diagnostic imaging
  • Leiomyoma / therapy*
  • Lipectomy*
  • Treatment Outcome
  • Ultrasonography, Interventional*
  • Uterine Neoplasms / diagnostic imaging
  • Uterine Neoplasms / therapy*